Yes, histological analyses can predict both efficacy and safety. For instance, examining liver biopsies can reveal hepatotoxicity, while studying cardiac tissue can identify cardiotoxic effects. Moreover, changes in tumor morphology after treatment can indicate the efficacy of anticancer drugs.
